These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21031152)

  • 1. Flexible Cure Rate Modeling Under Latent Activation Schemes.
    Cooner F; Banerjee S; Carlin BP; Sinha D
    J Am Stat Assoc; 2007 Jun; 102(478):560-572. PubMed ID: 21031152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.
    Klement RJ; Allgäuer M; Andratschke N; Blanck O; Boda-Heggemann J; Dieckmann K; Duma M; Ernst I; Flentje M; Ganswindt U; Hass P; Henkenberens C; Imhoff D; Kahl HK; Krempien R; Lohaus F; Nestle U; Nevinny-Stickel M; Petersen C; Schmitt V; Semrau S; Sterzing F; Streblow J; Wendt TG; Wittig A; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):841-9. PubMed ID: 26972657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint longitudinal and time-to-event cure models for the assessment of being cured.
    Barbieri A; Legrand C
    Stat Methods Med Res; 2020 Apr; 29(4):1256-1270. PubMed ID: 31213153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric spatial cure rate models for interval-censored time-to-relapse data.
    Banerjee S; Carlin BP
    Biometrics; 2004 Mar; 60(1):268-75. PubMed ID: 15032798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the time-dependent predictive accuracy for event-to-time outcome with a cure fraction.
    Wang Z; Wang X
    Pharm Stat; 2020 Nov; 19(6):955-974. PubMed ID: 32776646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting parametric cure models in R using the packages cuRe and rstpm2.
    Jensen RK; Clements M; Gjærde LK; Jakobsen LH
    Comput Methods Programs Biomed; 2022 Nov; 226():107125. PubMed ID: 36126436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian Mixture Cure Rate Model for Estimating Short-Term and Long-Term Recidivism.
    de la Cruz R; Fuentes C; Padilla O
    Entropy (Basel); 2022 Dec; 25(1):. PubMed ID: 36673197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian cure fraction models with measurement error in the scale mixture of normal distribution.
    Marinho ARS; Loschi RH
    Stat Methods Med Res; 2020 Sep; 29(9):2411-2444. PubMed ID: 31928318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian destructive weighted Poisson cure rate model and an application to a cutaneous melanoma data.
    Rodrigues J; Cancho VG; de Castro M; Balakrishnan N
    Stat Methods Med Res; 2012 Dec; 21(6):585-97. PubMed ID: 21131689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A penalized likelihood approach for mixture cure models.
    Corbière F; Commenges D; Taylor JM; Joly P
    Stat Med; 2009 Feb; 28(3):510-24. PubMed ID: 19003981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cure rate survival data under proportional odds model.
    Gu Y; Sinha D; Banerjee S
    Lifetime Data Anal; 2011 Jan; 17(1):123-34. PubMed ID: 20521166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cure models with adaptive activation for modeling cancer survival.
    Jiang Q; Basu S
    Stat Methods Med Res; 2024 Feb; 33(2):227-242. PubMed ID: 38298015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling geographically referenced survival data with a cure fraction.
    Cooner F; Banerjee S; McBean AM
    Stat Methods Med Res; 2006 Aug; 15(4):307-24. PubMed ID: 16886733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The single-index/Cox mixture cure model.
    Amico M; Van Keilegom I; Legrand C
    Biometrics; 2019 Jun; 75(2):452-462. PubMed ID: 30430553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A general class of promotion time cure rate models with a new biological interpretation.
    Gómez YM; Gallardo DI; Bourguignon M; Bertolli E; Calsavara VF
    Lifetime Data Anal; 2023 Jan; 29(1):66-86. PubMed ID: 36114312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation analysis for mixture Cox proportional hazards cure models.
    Zhou X; Song X
    Stat Methods Med Res; 2021 Jun; 30(6):1554-1572. PubMed ID: 33834919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized parametric cure models for relative survival.
    Jakobsen LH; Bøgsted M; Clements M
    Biom J; 2020 Jul; 62(4):989-1011. PubMed ID: 31957910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic checks in mixture cure models with interval-censoring.
    Scolas S; Legrand C; Oulhaj A; El Ghouch A
    Stat Methods Med Res; 2018 Jul; 27(7):2114-2131. PubMed ID: 27815495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The destructive negative binomial cure rate model with a latent activation scheme.
    Cancho VG; Bandyopadhyay D; Louzada F; Yiqi B
    Stat Methodol; 2013 Jul; 13():48-68. PubMed ID: 23585760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiparametric Bayesian estimation of quantile function for breast cancer survival data with cured fraction.
    Gupta C; Cobre J; Polpo A; Sinha D
    Biom J; 2016 Sep; 58(5):1164-77. PubMed ID: 27162061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.